Skip to main content

Displaying 4401 - 4420 of 4427

Basic page

Litigation Status Report

Basic page

The Most Frequently Asked HSR Questions

1. Where are the Act and the rules located? 16 CFR § 801-803, 15 U.S.C. § 18a and e-CFR 2. How much is the filing fee? $45,000 for transactions more than $50 MM but less than $100 MM (as adjusted)...

Defense Production Act of 1950

Mission
Competition
Law
Pub. L. No. 81–774, 123 Stat. 2006, codified in relevant part at 50 U.S.C. § 4558
Section 708 of the Act requires the Commission and the Department of Justice to participate in developing, implementing, monitoring, and reporting on voluntary agreements among industry members...

Deep Seabed Hard Minerals Act

Mission
Competition
Law
Pub. L. No. 96-283, 94 Stat. 553, codified in relevant part at 30 U.S.C. § 1413
Under Section 103(d) of this Act, the Administrator of the National Oceanic and Atmospheric Administration in the Department of Commerce must provide the Attorney General and the Federal Trade...

Lanham Trade-Mark Act

Mission
Competition
Consumer Protection
Law
Pub. L. 87–772, 76 Stat. 769; codified in relevant part at 15 U.S.C. § 1064
Section 14 of this Act authorizes the Commission, under certain conditions, to apply to the Patent and Trademark Office for the cancellation of registered trademarks.

Webb-Pomerene Act

Mission
Competition
Law
15 U.S.C. §§ 61-68
Under this Act, the Commission is responsible for receiving certain filings from export trade associations organized under the Act; investigating association operations that may adversely affect...

U.S. SAFE WEB Act

Mission
Competition
Consumer Protection
Law
Pub. L. No. 109-455, 120 Stat. 3372, extended by Pub. L. No. 116-173, 134 Stat. 837, codified at 15 U.S.C. §§ 41 et seq.
This Act, amending the FTC Act, provides the FTC with a number of tools to improve enforcement regarding consumer protection matters, particularly those with an international dimension, including...

Medicare Prescription Drug, Improvement, and Modernization Act of 2003

Mission
Competition
Law
Pub. L. No. 108-173, 117 Stat. 2066, codified in relevant part at 21 U.S.C. § 355(j) (Section 1102), 21 U.S.C. § 355 note (Sections 1111-1118)
Section 1102 provides that an applicant for an abbreviated new drug approval may forfeit certain exclusive marketing rights in specified circumstances, including an FTC or court determination that the...